FORMULATIONS OF FENOFIBRATE AND/OR FENOFIBRATE DERIVATIVES WITH IMPROVED ORAL BIOAVAILABILITY - Patent 1539117

(19)

(11)

EP 1 539 117 A1

(12)

(43)	Date of publication:
	15.06.2005 Bulletin 2005/24

(21)	Application number: 02801215.1

(22)	Date of filing: 20.12.2002

(51)	International Patent Classification (IPC)⁷: A61K 9/48, A61K 9/54, A61K 9/66, A61K 9/127

(86)	International application number:
	PCT/US2002/041093

(87)	International publication number:
	WO 2004/002458 (08.01.2004 Gazette 2004/02)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
	Designated Extension States:
	AL LT LV MK RO

(30)

Priority:

28.06.2002 US 392806 P
28.06.2002 US 392791 P

(71)	Applicant: Shire Laboratories Inc.
	Rockville, Maryland 20850 (US)

(72)	Inventors:
	SHOJAEI, Amir, H. Gaithersburg, MD 20878 (US) IBRAHIM, Scott, A. Burtonville, MD 20866 (US) BURNSIDE, Beth, A. Bethesda, MD 20814 (US)

(74)	Representative: Fisher, Adrian John et al
	CARPMAELS & RANSFORD43-45 Bloomsbury Square London WC1A 2RA London WC1A 2RA (GB)

(54)	FORMULATIONS OF FENOFIBRATE AND/OR FENOFIBRATE DERIVATIVES WITH IMPROVED ORAL BIOAVAILABILITY